We have studied voltage-dependent calcium channels in the A7r5 smooth muscle cell line by measuring the high-affinity binding of radiolabelled dihydropyridines (DHPs), whole-cell and single-channel currents in patchclamped cells, as well as cytosolic calcium ([Ca2+]i) in fura-2-loaded cell suspensions and monolayers. Intact A7r5 cells express saturable, high-affinity, voltage-sensitive DHP binding sites with pharmacological properties characteristic of L-type calcium channels. When cells were voltage clamped in the whole-cell configuration with near normal intra-and extracellular solutions, a DHP-sensitive inward current resembling the L-type calcium current was dominant. With barium (10 mM) as the charge carrier, peak inward currents were typically recorded at test potentials between 0 and +20 mV. Currents were blocked by extracellular cadmium with a half-maximal inhibitory concentration of -1/~M. Isoproterenol (1/~M) or forskolin (10 #M) increased currents in approximately half of the cells tested. Forskolin (10/~M) increased single-channel activity in five of eight cell-attached patches. After cells had been quiescent for several weeks, cell suspensions showed changes in resting [Ca2+]i in response to DHPs and increased potassium.
Introduction
Most studies of calcium channels in vascular smooth muscle have used freshly isolated cells, since tissue culture of these Offprint requests to: S. W. Jones cells is accompanied by considerable phenotypic modulation (Campbell and Campbell 1987) . These phenotypic changes may involve quantitative or qualitative changes in the expression of voltage-dependent calcium channels. However, the A7r5 cell line, isolated from embryonic rat aorta, has proven useful as a model system for the study of dihydropyridine (DHP)-sensitive calcium channels. Besides exhibiting a variety of structural and functional properties of vascular smooth muscle, confluent monolayers of A7r5 cells are electrically coupled and show evidence of spontaneous electrical activity (Kimes and Brandt 1976; van Renterghem et al. 1988) . Additionally, these cells have a voltage-and verapamil-sensitive calcium influx pathway (Ruegg et al. 1985) . Membranes isolated from A7r5 cells have saturable high-affinity DHP binding sites, and voltage-clamped whole-cell current measurements show the presence of Ltype calcium currents (Qar et al. 1988; van Renterghem et al. 1988 ). Whole-cell calcium currents recorded from these cells are often an order of magnitude greater than those recorded from freshly isolated vascular smooth muscle. Additionally, large amounts of cells can be conveniently grown in the laboratory, making it possible to do biochemical studies in parallel with electrophysiology. As such, the A7r5 cell line provides many advantageous features for exploring properties of calcium currents of vascular smooth muscle. This paper describes fundamental properties of both calcium channels and voltage-dependent changes in cytosolic calcium ([Ca2+] i) in the A7r5 cell line through the application of ligand binding, electrophysiological, and fluorometric techniques.
Materials and methods
Cells. A7r5 cells were acquired from American Type Cell Culture facilities and grown in Dulbecco's modified Eagle's medium (DMEM) containing penicillin (50 units/ml), streptomycin (50 units/ml), and 10% iron-supplemented calf serum (CS; Hyclone, Logan, Utah, USA). Experimental cells were allowed to reach confluence, whereupon serum levels were reduced to 0.5% for 1-3 weeks. For DHP binding assays, cells were grown in 12-well cluster dishes and the experiments were done with the cells attached to the dishes. Monday-ers of cells for fura-2 fluorescence experiments were grown on plastic coverslips in 12-well plates as previously described (Mene et al. 1987) .
For electrophysiology, confluent cells were trypsinized and replated in 35-mm dishes. Immediately after the cells attached to the dishes, they were treated with cytochalasin-D (1 #g/ml) in order to maintain a rounded morphology. All experiments were conducted within 2 days of replating.
DHP binding. Binding assays were conducted according to a modification of the methods of Greenberg et al. (1986) , which allowed us to conduct incubations with substrate-attached cells. The cells were rinsed with a balanced salt solution (BSS) containing (mM): NaC1 125, KC1 5, MgCI2 1.5, 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid, sodium salt (Na-HEPES)25, and glucose 10 (pH 7.4) and incubated in 2 ml buffer in the cluster dishes. The "depolarizing" or "high K +'', buffer contained (mM): NaC1 85, KC1 50, MgCI2 i, CaClz 2, Na-HEPES 50, and glucose 5 (pH 7.4); and the "polarizing" or "low K +, low Ca 2+'' buffer contained (mM): NaC1 85, KC1 5, MgC12 1, CaC12 0.5, cholinechloride 46.5, Na-HEPES 50, and glucose 5 (pH 7.4). (+)3H-PN-200-110 and nifedipine dissolved in ethanol were added in 2-/~1 aliquots. Cells were incubated in the dark for 90 min at room temperature, after which they were quickly rinsed with ice-cold buffer. NaOH was added to each well to extract all protein, followed by a rinse with H20. The cell extract was neutralized with HC1, scintillation cocktail was added, and the mixture was assayed for radioactivity in a scintillation counter.
Samples consisting of -105 cells provided enough material to make reliable measurements. Nonspecific binding was assumed to be that (+) bound in the presence of 1 pM nifedipine, and has been subtracted from all data presented. Specific binding was ~50% of total binding at 50 pM and -15% at 600 pM (+) . Values for the dissociation constant (Ka) and maximum binding (B~,~• were derived by weighted regression according to the method of Wilkinson (1961) .
Electrophysiology. For whole-celt recording, pipettes with resistances of 1.0-3.5 Mf~ were used to make high-resistance seals with the cell membrane. Voltage clamp was established using a List EPC-7 (Darmstadt, FRG) or Axopatch-lB (Axon Instruments, Burlingame, Calif., USA) patch-clamp amplifier. Voltage commands were given and data were obtained using an AT-type computer, pCLAMP software (CLAMPEX; Axon Instruments) and a Labmaster A-D converter (Scientific Solutions, Solon, Ohio, USA). The incoming signal was filtered at 3 or 5 kHz and digitized at 20 kHz. Leakage current was determined by hyperpolarizing the cell in 2.5 mV increments and was subtracted from depolarizing steps. Series resistance, typically 2-5 M~, remained uncompensated. With a series resistance of 5 M~I and currents smaller than 1 nA, we expect a maximum voltage error of 5 mV. The time constant for voltage clamp in the worst case (5 Mft series resistance, 50 pF capacitance) would be 0.25 ms. Space clamp should present little problem as cells were spherical and less than 50 #m in diameter. Pipette solutions consisted of (mM): CsC1 or KC1 120, MgC12 4, adenosine triphosphate, sodium salt (Na2ATP) 5, ethylene bis(oxonitrilo)tetraacetate, cesium salt (Cs2EGTA) 1, and N-methyl-D-glucamine HEPES 2.5, pH 7.2; and bath solutions contained (raM): NaC1 112.5, KC1 5, BaC12 or CaC12 10, MgC12 1.2, Na-HEPES 2.5, and glucose 10, pH 7.4.
For single-channel recording, pipettes of --5 Mf~ were made from borosilicate glass (World Precision Instruments, New Haven, Conn., USA). The pipette contained (mM): BaC12 90, and HEPES 10, pH 7.4. Following seal formation, membrane potential was zeroed with an extracellular solution containing (mM): KC1 120, K-EGTA i0, and K-HEPES 10. The analog current signal was filtered at 3 kHz and digitized at 10 kHz. Null sweeps were subtracted from records with openings in order to cancel capacitative transients and leakage currents. On analysis, the data was digitally filtered at 1 kHz. Bathing solutions were superfnsed by gravity feed and switched between reservoirs containing drugs and drug free solutions, pCLAMP, Lotus 1-2-3, (Lotus Corp. Cambridge, Mass., USA) and Micrografx Draw (Richardson, Texas, USA) were used for analysis and figure preparation.
Cytosolic [Ca2 § Confluent cells were treated with trypsin and suspended in BSS with 0.5 % bovine serum albumin. After washing, cells were incubated with 0.5/~M the acetoxymethyl ester of fura-2 (fura-2-AM) for 30 min at 37 ~ rinsed and placed into a glass cuvette which was thermostated at 37 ~ and stirred continuously. Monolayers grown on plastic coverslips were incubated with 2 ~tM fura-2-AM in DMEM with 0.5 % CS for 30 min at 37 ~ C. Excitation and emission wavelengths were 339 and 500 nm respectively. Calibration was accomplished by adding 20/~g/ml digitonin followed by 12 mM EGTA (suspensions) or 10 k!M ionomycin followed by i mM MnClz (monolayers). Calculations were made assuming a K~ of 220 nM, for the fura-2 Ca z+ complex.
Materials. L(-)Isoproterenol and cytochalasin-D were purchased from
Sigma (St. Louis, Mo., USA) Nifedipine, Bay K 8644, forskolin, and ionomycin were purchased from Calbiochem (La Jolla, Calif. USA). Fura-2-AM was fi'om Molecular Probes (Eugene, Ore., USA). (+)3H-PN-200-110 was purchased from New England Nuclear (Boston, Mass., USA). (+)202-791 was a gift from Sandoz, Basel, Switzerland. All other reagents were from standard sources.
Results

DHP binding
Intact adherent A7r5 cells have saturable, high-affinity, voltage-sensitive (+)3H-PN-200-110 binding sites (Fig. 1A) . In high K § (50 raM) buffer the saturation isotherm was fitted assuming a single high-affinity site, Kd = 54 + 9 pM Ca 2+ buffer. This is the result of a single experiment which was repeated three times with the same result. Curves are drawn according to the law of mass action assuming a single site and fit by eye (mean + SE, n = 3). When the assay was conducted in low Ca 2+, low K + buffer (in order to maintain cell membrane potential), then the data were fitted assuming a single site with a considerably lower affinity, K d = 167 + 37 pM (n = 3). Maximum binding was 47 + 2 and 47 + 4 fmol/106 cells under depolarized and polarized conditions respectively, or about 30,000 sites per cell. Displacement of (+)3H-PN-200-110 by nifedipine was also voltage sensitive, with nifedipine exhibiting a lower inhibition constant (K~) in high K + buffer (Fig. 1B) . When cells were incubated with 50 pM (+)3-H-PN-200-110, nifedipine displaced (+)3H-PN-200-110 in a dose-dependent manner. In both the high K + and low K +, low Ca 2 § buffers, (+)3H-PN-200-110 displacement by nifedipine was fit by eye according to an equation derived by the law of mass action assuming a single affinity site. Values for Ki were calculated from the fitted curves (Cheng and Prusoff 1973) and were 260 and 1600 pM in the high K + and low K +, tow Ca 2+ buffers respectively.
Electrophysiology
The magnitude of inward currents was highly variable among preparations of cells as well as between individual cells from the same preparation. Peak currents ranging from < 0.05 to 2 nA were recorded at test potentials between 0 and +20 mV with 10 mM barium as the charge carrier. A typical family of currents elicited from a holding potential of -60 mV is shown in Fig. 2A . With calcium as the charge carrier, the peak currents were smaller, and the currents inactivated over tens of milliseconds.
Calcium currents dominated voltage-activated cation fluxes in these cells, and could be well resolved even with near normal intra-and extracellular solutions. Inward currents were similar in terms of their kinetics and amplitudes with either potassium or cesium as the primary cation in the pipette solution. With potassium, outwared currents were more noticeable but variable at strongly depolarized test potentials (i.e. > + 40 mV). "Rundown" of the current was variable, and often pronounced.
In most cases currents were characteristic of the L-type calcium channel. In some instances a "shoulder" was noted in current voltage curves and a rapidly inactivating lowthreshold current was obvious in cells indicating the presence of T-type current. Rarely, was such a current dominant. In most cases, however, the shape of current traces elicited from a holding potential of -80 mV appeared indentical to those from a holding potential of -40 mV. With holding potentials more positive than -50 mV proportionately less current could be activated; at a holding potential of -20 mV all current was inactivated (Fig. 2 B, C) .
Inward currents carried by 10 mM barium could be completely blocked by cadmium (half-maximal inhibitory concentration, ICs0 = 1/~M) (Fig. 3) , and were sensitive to I#M DHP calcium channel agonists (Fig. 4) and antagonists (not shown).
The fl-adrenergic agonist isoproterenol (1 #M) increased the inward current in approximately half of the cells tested, although responsiveness varied between preparations. When present, this effect was mimicked by forskolin, a direct activator of adenylate cyclase. A.
--7 -'6 -5 Iog[Cd 2+] (M) Fig. 3 A-C. Calcium currents are blocked by micromolar concentrations of cadmium (Cd2+). A Superimp0sed ctirrents recorded before, during, and ~/fter application of 1/~M Cd z+. The holding potential.was -60 mV and the test potential was +10 mV. B Current voltage relationships before, during and after application of Cd 2+. C Dose/response curve for Cd 2+ . Currents during Cd 2+ application were divided by the average of the control currents immediately before and after Cd 2+ ffpplication in order to correct for "run-down'. The curve was drawn according to the law of mass action assuming a single binding site and fit to the data by eye to a half-maximal inhibitory concentration of 1 #M. All data in this figure are from the same cell. External barium concentration was 10 mM Control values are an average of current amplitudes before drug application and after washout of the drug in order to correct for rundown. Cells with a current rundown of greater than 509/0 between control and washout were discarded from this analysis. Effects of these drugs on a particularly stable cell are shown in Fig. 5 . Currents were potentiated at all voltages uniformly, and the shape of the current trace was not obviously changed.
Single channels were observed in most cell-attached patches. Openings were short and difficult to resolve in control conditions, but additions of Bay K 8644 to the bath led to a characteristic increase in channel open times. In five of eight patches, application of 10 ktM forskolin led to a further increase in channel activity (Fig. 6) . When the experiment lasted long enough to permit removal of the forskolin (3 cases), the potentiation was reversible. Forskolin does not obviously change channel kinetics, but reduced the number of sweeps with no channel openings. Thus, the effects observed here appear similar to those seen for/3-adrenergic agonists in cardiac myocytes (Osterrieder et al. 1982; Brum et al. 1984; Kameyama et al. 1985) .
Cytosolic [Ca2+]i
Suspended cells had resting [Ca2+]j of -150 nM. Cells that had been confluent and serum-deprived for less than 1 week before experiments showed little or no change in [Ca2+]i when Bay K 8644, nifedipine, or potassium were added. Cells were more responsive with increasing time in culture following confluence (Fig. 7) .
The resting [Ca2+]i in confluent monolayers of fura-2-loaded A7r5 cells ranged from 200 to 250 nM. However, most monolayers exhibited episodes of spontaneous, rapid changes in [Ca2+]i. On chelation of extracellular calcium with excess EGTA or upon addition of nifedipine, these spontaneous transients ceased. Addition of the calcium channel agonist Bay K 8644 caused a dramatic increase in the frequency of these calcium transients (Fig. 8) . The calcium channel antagonist nifedipine led to an abrupt cessation of the [Ca2+]i elevations and a prompt return of [Ca2+]i to the resting level.
Discussion
We have demonstrated the presence of functional calcium channels in the A7r5 cell line by DHP binding, electrophysiological, and fluorometric techniques. The predominant calcium channel observed here shares pharmacological, ki'-netic and voltage dependent properties of L-type calcium channels found in smooth muscle and cardiac tissues (Hess et al. 1986 ).
More rarely, T-type currents were observed, characterized by rapid inactivation with barium as the charge carrier and a distinct shoulder on current voltage curves. T-currents have been reported in these cells by some (Fish et al. 1988; McCarthy and Cohen 1989) but not by others (van Renterghem et al. 1988) .
Dihydropyridines
The affinity of (+) for binding sites in A7r5 cells under polarizing and depolarizing conditions are in excellent agreement with those reported in intact PC12 cells (Kunze et al. 1987; Greenberg et al. 1986 ), cardiac cells (Kokubun et al. 1986 ), myometrial cells (Honore et al. 1989) as well as vascular smooth muscle tissue (Morel and Godfraind 1987) , which range from 40 to 65 pM in high potassium solutions. McCarthy and Cohen (1989) Binding studies with intact cells (Fig. 1 ) demonstrated the voltage-dependent binding of DHPs (Bean 1984; Sanguinetti and Kass 1984) . Since the data were fitted well assuming a single binding site, most if not all binding sites are voltage-sensitive and thus reside in the plasma membrane. Also, because no fractionation of the cells is involved, a more quantitative assessment of the number of binding sites per cell can be gained than in binding studies with isolated plasma membranes.
We can compare estimates of channel numbers from binding studies and from electrophysiology. At 0 mV in 90 mM barium, the single-channel amplitude was 1.1 pA and channels were open -0.4% of the time. Under those conditions, the whole-cell current was -20 pA, which corresponds to -4500 channels per cell. That is -15% of the number of DHP binding sites. This calculation is subject to error from cell-to-cell variability, especially since 0 mV is near the threshold for activation in 90 mM barium. In skeletal muscle, the discrepancy between DHp binding sites and functional calcium channels is more extreme (Schwartz et al. 1985) . It is possible that some DHP binding sites in smooth muscle are not calcium channels, or that some channels do not gate normally under whole-cell conditions.
fl-Adrenergic potentiation of calcium current
Although not all cells were responsive to the fl agonist isoproterenol, when present the increase in calcium current was clear. In particular, the effect was reversible, with a slow time course consistent with a second-messenger-mediated action (Fig. 5) . Isoproterenol and forskolin also increased cyclic adenosine 3',5'-phosphate (cAMP) levels measured by radioimmunoassay (data not shown), suggestive of in-volvement of the cAMP cascade, as for fi-adrenergic potentiation of calcium currents in cardiac cells (Kameyama et al. 1985) .
Potentiation of calcium currents in vascular smooth muscle by fl-adrenergic agonists was not expected, since t3 agonists are vasorelaxants and calcium mediates muscle contraction. However, the relationship between [Ca2+]~ and contraction of smooth muscle is complex. Recent studies with tracheal smooth muscle suggest that increases in [Ca2+]~, resulting from calcium influx, can be concomitant with relaxation (Takuwa et al. 1988) .
Adrenergic agonists previously have been reported to increase or decrease smooth muscle calcium currents, acting through a,/3, or y-adrenergic receptors (Droogmans et al. 1987; Pacaud et al. 1987; Nelson et al. 1988; Benham and Tsien 1988) . A similar discrepancy exists for activators of protein kinase C, which have been reported to enhance (Sperti and Colucci 1987; Fish et al. 1988) or inhibit (Galizzi et al. 1987 ) calcium currents in A7r5 cells. In our hands, neither phorbol esters 4-/3 phorbol 12-myristate 13-acetate, PMA, and 12-0 tetradecanoyl phorbol 13-acetate, TPA, 0.1 and 1.0 fzM) nor the calcium mobilizing hormones arginine vasopressin (100 nM) and endothelin (100 nM) had any effect on calcium currents in A7r5 cells. The explanation of this variability is not clear.
Calcium channels and [CaZ+]i
Cells that had been confluent for several weeks showed increases in [Ca2+]i in response to high extracellular potassium or DHP agonists, whereas cells at earlier stages were consistently unresponsive. This might suggest an increase in the number of functional calcium channels, but the number of DHP binding sites per cell was unchanged with time in culture, or with the proliferative state of the cells. The increase in channel activity might result from a more negative resting potential as the cells are in culture longer (Blennerhassett et al. 1989) , leading to removal of voltage-dependent inactivation of calcium channels. Alternatively, phenotypic modulation during maturation might directly enhance calcium channel function.
Confluent, substrate-attached monolayers of ATr5 cells showed spontaneous oscillations in [Ca2+]i. These events depend on calcium influx through L-type calcium channels, as the transient increases in [Ca2+]i were prevented by DHP antagonists, and the frequency and amplitude of the transients were increased by DHP agonists. This suggests that the oscillations are due to synchronous action potential among electrically coupled cells (van Renterghem et al. 1988) throughout the large (0.64 cm 2) optical field of the photomultiplier. Action-potential-driven oscillations in [Ca2+]i , reported previously for pituitary cells (Schlegel et al. 1987 ) contrast with superficially similar oscillations resulting from calcium release from intracellular stores (Woods et al, 1986) . Although vascular smooth muscle cells do not fire action potentials under normal circumstances (Burnstock et al. 1963) , such activity in A7r5 cells may provide important insights into the factors which regulate excitability in pathological conditions such as coronary vascular spasm.
In summary, the ability to combine the modalities of ligand binding, electrophysiology and fluorescence in the same preparation makes ATr5 cells attractive for the study of vascular smooth muscle excitability. This cell line provides us with an excellent in vitro model system which can be used to investigate a variety of questions regarding electrical excitability in vascular smooth muscle. Presently, phenotypic instability of A7r5 cells in culture represents a drawback of this system. However, an understanding of the factors which influence these changes may provide important clues as to how mechanisms which regulate excitability work in vivo.
